Pulmonary Arterial Hypertension (PAH) demands a personalized, multidisciplinary approach, encompassing specialized knowledge and novel treatments, a requisite often unfulfilled in remote regions due to significant gaps in access, expertise, and resources. The dearth of specialized PH centers and the ensuing reliance on general practitioners, compounded by geographical isolation from expansive medical communities, accentuates the urgency of integrating innovative treatments and the latest clinical trial data to enhance patient outcomes and refine risk management strategies. Constrained resources in these areas further impede healthcare professionals' capacity to stay updated on groundbreaking guidelines, emergent therapies, and advancements in personalized, multidisciplinary care essential for managing PAH effectively. Complicating this scenario are prevailing technology and connectivity challenges, which curtail the adoption of telehealth initiatives and inhibit participation in telementoring programs — key conduits for disseminating knowledge on avant-garde therapies and clinical developments. Consequently, a compelling need emerges for a strategic initiative, meticulously designed enable early detection, convey insights on current and novel treatments, disseminate pivotal clinical trial data, and elucidate strategies for individualized, multidisciplinary care to healthcare providers via telementoring. This initiative aspires to bridge the identified gaps, cultivate collaboration, and significantly elevate the standard of PAH management in underserved, resource-limited rural environments.